PATRICK J SIMPSON
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology
- Where
- PINEHURST, NC
- NPI
- 1841234887
- Received
- $579,343 in 1,119 records, 2019 to 2025
- As principal investigator
- $1,067,222 of research payments to others in 106 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 125 | $50,667 |
| 2024 | General payment | 192 | $85,172 |
| 2023 | General payment | 163 | $75,772 |
| 2022 | General payment | 118 | $49,841 |
| 2021 | General payment | 98 | $61,804 |
| 2020 | General payment | 121 | $81,039 |
| 2019 | General payment | 302 | $175,045 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 234 | $483,071 |
| Travel and Lodging | 152 | $57,239 |
| Food and Beverage | 723 | $27,201 |
| Consulting Fee | 4 | $11,780 |
| Education | 6 | $51 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | BridgeBio Pharma, Inc. | $14 | Food and Beverage | In-kind items and services | Attruby Drug, Cardiomyopathy | 2025 | |
| 2025-12-22 | Boston Scientific Corporation | $23 | Food and Beverage | In-kind items and services | WATCHMAN Access System Device, WATCHMAN_IC | 2025 | |
| 2025-12-16 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $20 | Food and Beverage | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2025 | |
| 2025-12-08 | CORDIS US CORP. | $19 | Food and Beverage | In-kind items and services | MYNX CONTROL VENOUS Device, Cardiology/Vascular Diseases | 2025 | |
| 2025-12-03 | Boston Scientific Corporation | $130 | Food and Beverage | In-kind items and services | AVVIGO Guidance System Device, AVVIGO_IC | 2025 | |
| 2025-12-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | $7 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-12-02 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $7 | Food and Beverage | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2025 | |
| 2025-11-28 | Boston Scientific Corporation | $5,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | WATCHMAN Access System Device, WATCHMAN_IC | 2025 | |
| 2025-11-28 | Boston Scientific Corporation | $7 | Travel and Lodging | Cash or cash equivalent | WATCHMAN Access System Device, WATCHMAN_IC | 2025 | |
| 2025-11-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $3,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-11-19 | Medtronic, Inc. | $73 | Food and Beverage | In-kind items and services | COBALT DR MRI SURESCAN Device, Implantable Cardioverter Defibrillators (ICDs) | 2025 | |
| 2025-11-13 | Boston Scientific Corporation | $125 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-11-13 | Alnylam Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | ONPATTRO Drug, Genetic Disease | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-11-11 | Boston Scientific Corporation | $21 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-11-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | $124 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-11-05 | CORDIS US CORP. | $21 | Food and Beverage | In-kind items and services | MYNX CONTROL VENOUS Device, Cardiology/Vascular Diseases | 2025 | |
| 2025-11-02 | Boston Scientific Corporation | $14 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-10-30 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | SHINGRIX Biological, VACCINES | 2025 | |
| 2025-10-27 | Boston Scientific Corporation | $18 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-10-24 | AngioDynamics, Inc. | $24 | Food and Beverage | In-kind items and services | ALPHAVAC Device, VIT | 2025 | |
| 2025-10-21 | Boston Scientific Corporation | $19 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-10-15 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-10-14 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-10-14 | Boston Scientific Corporation | $21 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-10-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-10-06 | Boston Scientific Corporation | $19 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-10-02 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-10-01 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-10-01 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | VYNDAQEL Drug, CARDIOVASCULAR | 2025 | |
| 2025-09-24 | Terumo Medical Corporation | $18 | Food and Beverage | In-kind items and services | ANGIO-SEAL Device, VASCULAR ACCESS | 2025 | |
| 2025-09-22 | Boston Scientific Corporation | $19 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-09-18 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-09-17 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-09-12 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-09-11 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-09-11 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $4 | Food and Beverage | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2025 | |
| 2025-09-10 | GlaxoSmithKline, LLC. | $13 | Food and Beverage | In-kind items and services | SHINGRIX Biological, VACCINES | 2025 | |
| 2025-09-08 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-09-02 | Shockwave Medical, Inc | $15 | Food and Beverage | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Cardiology | 2025 | |
| 2025-08-28 | Lilly USA, LLC | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-08-28 | Lilly USA, LLC | $1,575 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-08-27 | Amgen Inc. | $108 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-25 | Lilly USA, LLC | $820 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-08-22 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-08-21 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-08-20 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-08-20 | Boston Scientific Corporation | $23 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-08-18 | Bayer Healthcare Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-08-14 | Boston Scientific Corporation | $22 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-08-13 | Teleflex LLC | $19 | Food and Beverage | In-kind items and services | VASCBAND Device, INTERVENTIONAL ACCESS | 2025 | |
| 2025-08-05 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-08-05 | BridgeBio Pharma, Inc. | $15 | Food and Beverage | In-kind items and services | Attruby Drug, Cardiomyopathy | 2025 | |
| 2025-08-05 | Alnylam Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | ONPATTRO Drug, Genetic Disease | 2025 | |
| 2025-08-01 | Philips North America LLC | $21 | Food and Beverage | Cash or cash equivalent | Coronary Other Device, Medical Device | 2025 | |
| 2025-07-25 | Stryker Corporation | $17 | Food and Beverage | In-kind items and services | FLOWTRIEVER Device, INARI MEDICAL | 2025 | |
| 2025-07-22 | Boston Scientific Corporation | $20 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-07-15 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-07-15 | Boston Scientific Corporation | $4 | Food and Beverage | In-kind items and services | BodyGuardian Device, CDS - BG Mini Plus_RM | 2025 | |
| 2025-07-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $3,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-07-07 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | REPATHA Biological, Cardiovascular | 2025 | |
| 2025-07-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-06-30 | Boston Scientific Corporation | $30 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-06-23 | Boston Scientific Corporation | $21 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-06-20 | Boston Scientific Corporation | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | WATCHMAN Access System Device, WATCHMAN_IC | 2025 | |
| 2025-06-20 | Boston Scientific Corporation | $19 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-06-19 | Boston Scientific Corporation | $113 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-06-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | $27 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-06-12 | Boston Scientific Corporation | $7 | Food and Beverage | In-kind items and services | BodyGuardian Device, CDS - BG Mini Plus_RM | 2025 | |
| 2025-06-11 | Bayer Healthcare Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-06-10 | BridgeBio Pharma, Inc. | $15 | Food and Beverage | In-kind items and services | Attruby Drug, Cardiomyopathy | 2025 | |
| 2025-06-06 | Boston Scientific Corporation | $21 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-06-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-05-28 | Bayer Healthcare Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-05-23 | Shockwave Medical, Inc | $10 | Food and Beverage | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Cardiology | 2025 | |
| 2025-05-21 | BridgeBio Pharma, Inc. | $122 | Food and Beverage | In-kind items and services | Attruby Drug, Cardiomyopathy | 2025 | |
| 2025-05-19 | Boston Scientific Corporation | $138 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-05-19 | Boston Scientific Corporation | $22 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-05-15 | Boston Scientific Corporation | $125 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-05-15 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $18 | Food and Beverage | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2025 | |
| 2025-05-09 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-05-08 | ABIOMED | $45 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-06 | Shockwave Medical, Inc | $17 | Food and Beverage | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Cardiology | 2025 | |
| 2025-05-05 | Boston Scientific Corporation | $23 | Food and Beverage | In-kind items and services | WATCHMAN Access System Device, WATCHMAN_IC | 2025 | |
| 2025-04-30 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-04-28 | Philips North America LLC | $40 | Food and Beverage | Cash or cash equivalent | Coronary Other Device, Medical Device | 2025 | |
| 2025-04-22 | Lilly USA, LLC | $10 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-04-15 | Boston Scientific Corporation | $21 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-04-10 | Shockwave Medical, Inc | $144 | Food and Beverage | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Cardiology | 2025 | |
| 2025-04-08 | Bayer Healthcare Pharmaceuticals Inc. | $15 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-04-04 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-04-02 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-03-31 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-03-31 | Boston Scientific Corporation | $18 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-03-28 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-03-27 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiovascular | 2025 | |
| 2025-03-25 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-03-24 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | VYNDAQEL Drug, CARDIOVASCULAR | 2025 | |
| 2025-03-21 | Abbott Laboratories | $23 | Food and Beverage | In-kind items and services | AMPLATZER AMULET Device, Structural Heart | 2025 | |
| 2025-03-20 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-03-20 | ABIOMED | $31 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-20 | Bayer Healthcare Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-03-19 | Boston Scientific Corporation | $19 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-03-19 | Lilly USA, LLC | $9 | Food and Beverage | In-kind items and services | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-03-18 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-03-13 | Boston Scientific Corporation | $10 | Food and Beverage | In-kind items and services | BodyGuardian Device, CDS - BG Mini Plus_RM | 2025 | |
| 2025-03-11 | Abbott Laboratories | $18 | Food and Beverage | In-kind items and services | CARDIOMEMS Device, Structural Heart | 2025 | |
| 2025-03-10 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-02-27 | Lilly USA, LLC | $1,718 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2025 | |
| 2025-02-18 | Boston Scientific Corporation | $32 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-02-11 | Abbott Laboratories | $15 | Food and Beverage | In-kind items and services | DIAMONDBACK CORONARY Device, Vascular | 2025 | |
| 2025-02-10 | Shockwave Medical, Inc | $13 | Food and Beverage | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Cardiology | 2025 | |
| 2025-02-03 | Boston Scientific Corporation | $19 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-01-27 | Boston Scientific Corporation | $20 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-01-27 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-01-21 | Boston Scientific Corporation | $20 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-01-21 | Boston Scientific Corporation | $3 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-01-14 | Philips North America LLC | $18 | Food and Beverage | Cash or cash equivalent | Coronary Other Device, Medical Device | 2025 | |
| 2025-01-13 | Boston Scientific Corporation | $18 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2025-01-08 | ABIOMED | $29 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-08 | CARDIVA MEDICAL, INC. | $15 | Food and Beverage | In-kind items and services | OPTOWIRE Device, DEVICES | 2025 | |
| 2025-01-07 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $63 | Food and Beverage | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2025 | |
| 2025-01-07 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | 2025 | |
| 2025-01-06 | Boston Scientific Corporation | $23 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2025 | |
| 2024-12-20 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-12-18 | CORDIS US CORP. | $19 | Food and Beverage | In-kind items and services | Mynx Venous VCD Device, CARDIOVASCULAR | 2024 | |
| 2024-12-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | $4,075 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-12-16 | Boston Scientific Corporation | $103 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX IC | 2024 | |
| 2024-12-11 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $19 | Food and Beverage | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2024 | |
| 2024-12-11 | Inspire Medical Systems, Inc. | $15 | Food and Beverage | In-kind items and services | INSPIRE Device, NEUROLOGY | 2024 | |
| 2024-12-10 | Kiniksa Pharmaceuticals International, plc | $20 | Food and Beverage | In-kind items and services | Arcalyst Drug, Rheumatology | 2024 | |
| 2024-12-10 | Boston Scientific Corporation | $2 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX IC | 2024 | |
| 2024-12-06 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-12-05 | AstraZeneca Pharmaceuticals LP | $20 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-12-04 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-12-02 | Boehringer Ingelheim Pharmaceuticals, Inc. | $3,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-11-21 | Boston Scientific Corporation | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | WATCHMAN Access System Device, WATCHMAN_IC | 2024 | |
| 2024-11-19 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-11-15 | Boston Scientific Corporation | $18 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-11-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $979 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-11-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | $119 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-11-14 | Kestra Medical Technology Services, Inc. | $19 | Food and Beverage | Cash or cash equivalent | Assure WCD Device, Cardiology | 2024 | |
| 2024-11-12 | Bayer Healthcare Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-11-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $3,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-11-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $6 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-11-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $5 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-11-07 | Boston Scientific Corporation | $941 | Travel and Lodging | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-11-07 | Boston Scientific Corporation | $102 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-11-07 | Merck Sharp & Dohme LLC | $13 | Food and Beverage | In-kind items and services | VERQUVO Drug, CARDIOVASCULAR | 2024 | |
| 2024-11-04 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-11-04 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-11-01 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-10-31 | Lilly USA, LLC | $1,150 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-10-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | $29 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-10-23 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $20 | Food and Beverage | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2024 | |
| 2024-10-21 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-10-18 | Boston Scientific Corporation | $18 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-10-16 | Bayer Healthcare Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-renal | 2024 | |
| 2024-10-15 | Boston Scientific Corporation | $20 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-10-14 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-10-10 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-10-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | $124 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-10-03 | Boston Scientific Corporation | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | WATCHMAN Access System Device, WATCHMAN_IC | 2024 | |
| 2024-10-03 | Boston Scientific Corporation | $6 | Travel and Lodging | Cash or cash equivalent | WATCHMAN Access System Device, WATCHMAN_IC | 2024 | |
| 2024-10-02 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-10-01 | Lilly USA, LLC | $1,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-09-24 | Boston Scientific Corporation | $125 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-09-24 | Amgen Inc. | $37 | Food and Beverage | In-kind items and services | Repatha Biological, Cardiology | 2024 | |
| 2024-09-24 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-09-24 | Boston Scientific Corporation | $3 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-09-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-09-13 | Abbott Laboratories | $141 | Food and Beverage | In-kind items and services | COROFLOW Device, Vascular | 2024 | |
| 2024-09-11 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $16 | Food and Beverage | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2024 | |
| 2024-09-11 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | WAINUA Drug, Cardiovascular and Metabolism | 2024 | |
| 2024-09-05 | Kiniksa Pharmaceuticals International, plc | $14 | Food and Beverage | In-kind items and services | Arcalyst Drug, Not Applicable | 2024 | |
| 2024-08-28 | Kestra Medical Technology Services, Inc. | $14 | Food and Beverage | Cash or cash equivalent | Assure WCD Device, Cardiology | 2024 | |
| 2024-08-27 | Actelion Pharmaceuticals US, Inc. | $24 | Food and Beverage | In-kind items and services | UPTRAVI Drug, Cardiology | 2024 | |
| 2024-08-26 | Medtronic, Inc. | $39 | Food and Beverage | In-kind items and services | IN.PACT AV Device, Drug-Coated Balloons | 2024 | |
| 2024-08-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | $3,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-08-08 | Boston Scientific Corporation | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | WATCHMAN Access System Device, WATCHMAN_IC | 2024 | |
| 2024-08-07 | Medtronic, Inc. | $97 | Food and Beverage | In-kind items and services | IN.PACT AV Device, Drug-Coated Balloons | 2024 | |
| 2024-08-06 | Kiniksa Pharmaceuticals International, plc | $22 | Food and Beverage | In-kind items and services | Arcalyst Drug, Not Applicable | 2024 | |
| 2024-08-05 | Boston Scientific Corporation | $22 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-07-31 | Boehringer Ingelheim Pharmaceuticals, Inc. | $40 | Travel and Lodging | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-28 | Boston Scientific Corporation | $12 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-07-25 | Boston Scientific Corporation | $777 | Travel and Lodging | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-07-25 | Boston Scientific Corporation | $144 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-07-25 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2024 | |
| 2024-07-23 | Inari Medical, Inc. | $104 | Food and Beverage | In-kind items and services | FLOWTRIEVER CATHETER, S Device, VTE | 2024 | |
| 2024-07-22 | Boston Scientific Corporation | $19 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-07-18 | Boston Scientific Corporation | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | WATCHMAN Access System Device, WATCHMAN_IC | 2024 | |
| 2024-07-16 | Boston Scientific Corporation | $18 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-07-15 | Boston Scientific Corporation | $30 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $31 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-07-10 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | VYNDAQEL Drug, CARDIOVASCULAR | 2024 | |
| 2024-07-08 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $22 | Food and Beverage | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2024 | |
| 2024-07-03 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-07-01 | Boston Scientific Corporation | $19 | Food and Beverage | In-kind items and services | WATCHMAN FLX Device, WATCHMAN FLX_IC | 2024 | |
| 2024-07-01 | Kiniksa Pharmaceuticals International, plc | $14 | Food and Beverage | In-kind items and services | Arcalyst Drug, Not Applicable | 2024 |
The latest 200 records of 1,119.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-12 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $10,549 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-12-10 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $68,777 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-11-21 | Boehringer Ingelheim Pharma GmbH & Co.KG | FIRSTHEALTH OF THE CAROLINAS | $6,676 | EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety o | 2025 |
| 2025-10-02 | Janssen Research & Development, LLC | PINEHURST MEDICAL CLINIC INC | $173 | A Non-Interventional Survey Study on the Preferences of Patients with Atrial Fibrillation and Physicians Treating Atrial | 2025 |
| 2025-07-28 | Boehringer Ingelheim International GmbH | FIRSTHEALTH OF THE CAROLINAS | $359 | EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety o | 2025 |
| 2025-07-28 | Boehringer Ingelheim International GmbH | FIRSTHEALTH OF THE CAROLINAS | $36 | EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety o | 2025 |
| 2025-07-28 | Boehringer Ingelheim International GmbH | FIRSTHEALTH OF THE CAROLINAS | $34 | EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety o | 2025 |
| 2025-07-23 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $8,180 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-06-23 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $4,824 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-06-20 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $18,432 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-05-21 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $13,094 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-04-23 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $17,440 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-03-21 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $23,886 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-02-19 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $16,613 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2025-01-22 | AstraZeneca Pharmaceuticals LP | PINEHURST MEDICAL CLINIC, INC | $1,223 | This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the | 2025 |
| 2025-01-22 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $22,092 | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and | 2025 |
| 2024-12-31 | AstraZeneca Pharmaceuticals LP | PINEHURST MEDICAL CLINIC, INC | $216 | This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the | 2024 |
| 2024-12-18 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $4,510 | 70033093AFL3002 | 2024 |
| 2024-12-16 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $34,978 | 70033093AFL3002 | 2024 |
| 2024-11-20 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $33,704 | 70033093AFL3002 | 2024 |
| 2024-10-23 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $19,753 | 70033093AFL3002 | 2024 |
| 2024-09-25 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $1,488 | 70033093AFL3002 | 2024 |
| 2024-09-18 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $27,276 | 70033093AFL3002 | 2024 |
| 2024-08-19 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $32,606 | 70033093AFL3002 | 2024 |
| 2024-07-26 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $19,340 | 70033093AFL3002 | 2024 |
| 2024-06-25 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $6,869 | 70033093AFL3002 | 2024 |
| 2024-06-14 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $15,861 | 70033093AFL3002 | 2024 |
| 2024-05-22 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $23,965 | 70033093AFL3002 | 2024 |
| 2024-04-26 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $26,647 | 70033093AFL3002 | 2024 |
| 2024-03-27 | AstraZeneca Pharmaceuticals LP | PINEHURST MEDICAL CLINIC, INC | $2,100 | This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the | 2024 |
| 2024-03-25 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $24,528 | 70033093AFL3002 | 2024 |
| 2024-03-04 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $25,108 | 70033093AFL3002 | 2024 |
| 2024-01-26 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $15,347 | 70033093AFL3002 | 2024 |
| 2023-12-31 | AstraZeneca Pharmaceuticals LP | PINEHURST MEDICAL CLINIC, INC | $779 | This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the | 2023 |
| 2023-12-20 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $10,500 | 70033093AFL3002 | 2023 |
| 2023-12-15 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $12,435 | 70033093AFL3002 | 2023 |
| 2023-11-17 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $7,744 | 70033093AFL3002 | 2023 |
| 2023-10-25 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $19,650 | 70033093AFL3002 | 2023 |
| 2023-09-15 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $16,816 | 70033093AFL3002 | 2023 |
| 2023-08-16 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $7,649 | 70033093AFL3002 | 2023 |
| 2023-07-26 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $3,184 | 70033093AFL3002 | 2023 |
| 2023-06-14 | American Regent | Pinehurst Medical Clinic-East | $2,200 | Heart_FID | 2023 |
| 2023-06-07 | Janssen Research & Development, LLC | Pinehurst Medcl Clnc Endocrinology | $6,750 | 70033093AFL3002 | 2023 |
| 2023-04-12 | AstraZeneca Pharmaceuticals LP | PINEHURST MEDICAL CLINIC, INC | $7,546 | This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the | 2023 |
| 2023-01-19 | American Regent | Pinehurst Medical Clinic-East | $36,100 | Heart_FID | 2023 |
| 2022-12-31 | AstraZeneca Pharmaceuticals LP | PINEHURST MEDICAL CLINIC, INC | $1,221 | This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the | 2022 |
| 2022-10-17 | American Regent | Pinehurst Medical Clinic-East | $15,700 | Heart_FID | 2022 |
| 2022-08-03 | American Regent | Pinehurst Medical Clinic-East | $23,700 | Heart_FID | 2022 |
| 2022-04-27 | AstraZeneca Pharmaceuticals LP | PINEHURST MEDICAL CLINIC, INC | $11,826 | This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the | 2022 |
| 2022-04-20 | American Regent | Pinehurst Medical Clinic-East | $53,300 | Heart_FID | 2022 |
| 2021-12-21 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $234 | K-877-302 | 2021 |
| 2021-12-08 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $130 | K-877-302 | 2021 |
| 2021-12-01 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $1,703 | K-877-302 | 2021 |
| 2021-10-25 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $1,274 | K-877-302 | 2021 |
| 2021-09-24 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $1,590 | K-877-302 | 2021 |
| 2021-08-23 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $1,040 | K-877-302 | 2021 |
| 2021-07-23 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,592 | K-877-302 | 2021 |
| 2021-06-23 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $1,122 | K-877-302 | 2021 |
| 2021-05-25 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,162 | K-877-302 | 2021 |
| 2021-05-06 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $480 | K-877-302 | 2021 |
| 2021-04-26 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $888 | K-877-302 | 2021 |
| 2021-03-31 | Amgen Inc. | PINEHURST MEDICAL CLINIC, INC | $275 | Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9i (cvMOBIUS) | 2021 |
| 2021-03-22 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,439 | K-877-302 | 2021 |
| 2021-02-23 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $468 | K-877-302 | 2021 |
| 2021-01-25 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,478 | K-877-302 | 2021 |
| 2021-01-20 | Amgen Inc. | PINEHURST MEDICAL CLINIC, INC | $2,375 | Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9i (cvMOBIUS) | 2021 |
| 2020-12-24 | Amgen Inc. | PINEHURST MEDICAL CLINIC, INC | $1,250 | Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9i (cvMOBIUS) | 2020 |
| 2020-12-22 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $654 | K-877-302 | 2020 |
| 2020-12-17 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $420 | K-877-302 | 2020 |
| 2020-12-01 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,510 | K-877-302 | 2020 |
| 2020-11-02 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $468 | K-877-302 | 2020 |
| 2020-10-15 | American Regent | PINEHURST MEDICAL CLINIC INC | $23,700 | Heart_FID | 2020 |
| 2020-10-09 | Amgen Inc. | PINEHURST MEDICAL CLINIC, INC | $925 | Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9i (cvMOBIUS) | 2020 |
| 2020-09-24 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,162 | K-877-302 | 2020 |
| 2020-08-26 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $1,040 | K-877-302 | 2020 |
| 2020-07-24 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,244 | K-877-302 | 2020 |
| 2020-07-21 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $26 | K-877-302 | 2020 |
| 2020-07-09 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $266 | K-877-302 | 2020 |
| 2020-07-08 | American Regent | PINEHURST MEDICAL CLINIC INC | $42,400 | Heart_FID | 2020 |
| 2020-06-24 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $1,505 | K-877-302 | 2020 |
| 2020-06-01 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $1,575 | K-877-302 | 2020 |
| 2020-04-27 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $234 | K-877-302 | 2020 |
| 2020-04-22 | Amgen Inc. | PINEHURST MEDICAL CLINIC CLINICAL TRIALS | $7,800 | Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9i (cvMOBIUS) | 2020 |
| 2020-04-08 | American Regent | PINEHURST MEDICAL CLINIC INC | $19,900 | Heart_FID | 2020 |
| 2020-04-01 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $5,592 | K-877-302 | 2020 |
| 2020-03-20 | Amgen Inc. | PINEHURST MEDICAL CLINIC, INC | $21,900 | Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9i (cvMOBIUS) | 2020 |
| 2020-03-02 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $640 | K-877-302 | 2020 |
| 2020-02-19 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,384 | K-877-302 | 2020 |
| 2020-01-24 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $1,894 | K-877-302 | 2020 |
| 2020-01-13 | American Regent | PINEHURST MEDICAL CLINIC INC | $34,100 | Heart_FID | 2020 |
| 2020-01-09 | Amgen Inc. | PINEHURST MEDICAL CLINIC, INC | $4 | GALACTIC - HF | 2020 |
| 2020-01-02 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,046 | K-877-302 | 2020 |
| 2019-12-09 | American Regent | PINEHURST MEDICAL CLINIC INC | $993 | Heart_FID | 2019 |
| 2019-12-03 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $5,040 | K-877-302 | 2019 |
| 2019-11-08 | American Regent | PINEHURST MEDICAL CLINIC INC | $993 | Heart_FID | 2019 |
| 2019-10-25 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $234 | K-877-302 | 2019 |
| 2019-10-09 | American Regent | PINEHURST MEDICAL CLINIC INC | $15,600 | Heart_FID | 2019 |
| 2019-10-01 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $10,114 | K-877-302 | 2019 |
| 2019-08-12 | American Regent | PINEHURST MEDICAL CLINIC INC | $993 | Heart_FID | 2019 |
| 2019-07-18 | Kowa Research Institute, Inc. | PINEHURST MEDICAL CLINIC INC | $2,363 | K-877-302 | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Pinehurst, NC, county Moore County, NC, state North Carolina; placed by its city name.
| Measure | Place (city or town) Pinehurst, NC | County Moore County, NC | State North Carolina |
|---|---|---|---|
| Population B01003 | 18,256 | 104,876 | 10,730,404 |
| Population, 2020 census P1 | 17,581 | 99,727 | 10,439,388 |
| Median age B01002 | 60.6 | 43.0 | 39.1 |
| Under 18 B01001 | 16.3% | 21.7% | 21.8% |
| 65 and over B01001 | 41.0% | 24.1% | 17.2% |
| Households B11001 | 8,480 | 44,013 | 4,282,345 |
| Foreign born B05002 | 4.8% | 5.1% | 9.1% |
| Median household income B19013 | $109,802 | $86,080 | $72,388 |
| Median family income B19113 | $125,669 | $103,759 | $90,290 |
| Per capita income B19301 | $64,219 | $45,505 | $41,385 |
| Poverty rate B17001 | 4.3% | 10.1% | 13.0% |
| Unemployment rate B23025 | 5.2% | 4.8% | 4.7% |
| Civilian labor force B23025 | 6,064 | 44,506 | 5,336,863 |
| Mean commute (minutes) B08013 | 23.7 | 26.6 | 25.1 |
| Bachelor's degree or higher B15003 | 60.9% | 41.0% | 35.7% |
| Housing units B25001 | 9,540 | 50,280 | 4,895,668 |
| Owner-occupied B25003 | 85.2% | 76.4% | 66.6% |
| Renters B25003 | 14.8% | 23.6% | 33.4% |
| Median home value B25077 | $476,600 | $351,400 | $288,900 |
| Median gross rent B25064 | $1,664 | $1,254 | $1,228 |
| White, not Hispanic B03002 | 85.6% | 75.7% | 60.0% |
| Black B03002 | 1.1% | 8.9% | 20.0% |
| Hispanic or Latino B03002 | 4.3% | 7.8% | 11.3% |
| Asian B03002 | 1.8% | 1.2% | 3.3% |
| American Indian and Alaska Native B03002 | 0.9% | 0.4% | 0.8% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Pinehurst, NC.
Comments